SCHEMBL11301603

SCHEMBL11301603

O=C(NO)c1ccc(N(c2c(Cl)cccc2Cl)C2CCNC2=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 12/20 0.38
▸ HDAC8 Q9BY41 9/20 0.38
▸ HDAC1 Q13547 7/20 0.38
▸ HDAC2 Q92769 2/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ PSEN1 P49768 3/20 0.35
▸ PSEN2 P49810 3/20 0.35
▸ APH1B Q8WW43 3/20 0.35
▸ NCSTN Q92542 3/20 0.35
▸ APH1A Q96BI3 3/20 0.35
▸ PSENEN Q9NZ42 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301790 0.88 HDAC6 (0.36) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL11299163 0.88 HDAC6 (0.40) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL11301754 0.86 PSEN1 (0.42) HDAC6HDAC8HDAC1HDAC2PSEN1
SCHEMBL11299441 0.85 MAPK14 (0.37) KDM4EMEN1KMT2A
SCHEMBL11298752 0.84 HDAC8 (0.42) HDAC6HDAC8HDAC1PSEN1PSEN2
SCHEMBL11296595 0.84 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL11303328 0.83 HDAC8 (0.37) HDAC6HDAC8HDAC1PSEN1PSEN2
SCHEMBL11304464 0.81 HDAC8 (0.37) HDAC6HDAC8HDAC1PSEN1PSEN2
SCHEMBL11303268 0.81 ABL1 (0.37) HDAC6HDAC8HDAC1HDAC2HDAC3
SCHEMBL11305647 0.81 HDAC6 (0.41) HDAC6HDAC8HDAC1HDAC3HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback